The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Pulmonary Drug Delivery Devices & Systems Market Research Report 2024
Synopsis
Pulmonary Drug Delivery Devices/Systems include metered dose inhalers,dry powder inhalers,nebulizers and accessories.
The global Pulmonary Drug Delivery Devices & Systems market was valued at US$ 3046.1 million in 2023 and is anticipated to reach US$ 3966.6 million by 2030, witnessing a CAGR of 3.9% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Pulmonary Drug Delivery Devices & Systems, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pulmonary Drug Delivery Devices & Systems.
Report Scope
The Pulmonary Drug Delivery Devices & Systems market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Pulmonary Drug Delivery Devices & Systems market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pulmonary Drug Delivery Devices & Systems manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Hovione
3M Health Care
Bespak
BeyonDevices
GlaxoSmithKline
H&T Presspart
PARI Respiratory Equipment
Philips Respironics
SHL
Segment by Type
Metered Dose Inhalers
Dry Powder Inhalers
Nebulizers
Accessories
Segment by Application
Hospitals and Clinics
Homecare
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Pulmonary Drug Delivery Devices & Systems manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Pulmonary Drug Delivery Devices & Systems in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Pulmonary Drug Delivery Devices/Systems include metered dose inhalers,dry powder inhalers,nebulizers and accessories.
The global Pulmonary Drug Delivery Devices & Systems market was valued at US$ 3046.1 million in 2023 and is anticipated to reach US$ 3966.6 million by 2030, witnessing a CAGR of 3.9% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Pulmonary Drug Delivery Devices & Systems, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pulmonary Drug Delivery Devices & Systems.
Report Scope
The Pulmonary Drug Delivery Devices & Systems market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Pulmonary Drug Delivery Devices & Systems market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pulmonary Drug Delivery Devices & Systems manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Hovione
3M Health Care
Bespak
BeyonDevices
GlaxoSmithKline
H&T Presspart
PARI Respiratory Equipment
Philips Respironics
SHL
Segment by Type
Metered Dose Inhalers
Dry Powder Inhalers
Nebulizers
Accessories
Segment by Application
Hospitals and Clinics
Homecare
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Pulmonary Drug Delivery Devices & Systems manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Pulmonary Drug Delivery Devices & Systems in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Pulmonary Drug Delivery Devices & Systems Market Overview
1.1 Product Overview and Scope of Pulmonary Drug Delivery Devices & Systems
1.2 Pulmonary Drug Delivery Devices & Systems Segment by Type
1.2.1 Global Pulmonary Drug Delivery Devices & Systems Market Value Comparison by Type (2024-2030)
1.2.2 Metered Dose Inhalers
1.2.3 Dry Powder Inhalers
1.2.4 Nebulizers
1.2.5 Accessories
1.3 Pulmonary Drug Delivery Devices & Systems Segment by Application
1.3.1 Global Pulmonary Drug Delivery Devices & Systems Market Value by Application: (2024-2030)
1.3.2 Hospitals and Clinics
1.3.3 Homecare
1.4 Global Pulmonary Drug Delivery Devices & Systems Market Size Estimates and Forecasts
1.4.1 Global Pulmonary Drug Delivery Devices & Systems Revenue 2019-2030
1.4.2 Global Pulmonary Drug Delivery Devices & Systems Sales 2019-2030
1.4.3 Global Pulmonary Drug Delivery Devices & Systems Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Pulmonary Drug Delivery Devices & Systems Market Competition by Manufacturers
2.1 Global Pulmonary Drug Delivery Devices & Systems Sales Market Share by Manufacturers (2019-2024)
2.2 Global Pulmonary Drug Delivery Devices & Systems Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Pulmonary Drug Delivery Devices & Systems Average Price by Manufacturers (2019-2024)
2.4 Global Pulmonary Drug Delivery Devices & Systems Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Pulmonary Drug Delivery Devices & Systems, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Pulmonary Drug Delivery Devices & Systems, Product Type & Application
2.7 Pulmonary Drug Delivery Devices & Systems Market Competitive Situation and Trends
2.7.1 Pulmonary Drug Delivery Devices & Systems Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Pulmonary Drug Delivery Devices & Systems Players Market Share by Revenue
2.7.3 Global Pulmonary Drug Delivery Devices & Systems Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Pulmonary Drug Delivery Devices & Systems Retrospective Market Scenario by Region
3.1 Global Pulmonary Drug Delivery Devices & Systems Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Pulmonary Drug Delivery Devices & Systems Global Pulmonary Drug Delivery Devices & Systems Sales by Region: 2019-2030
3.2.1 Global Pulmonary Drug Delivery Devices & Systems Sales by Region: 2019-2024
3.2.2 Global Pulmonary Drug Delivery Devices & Systems Sales by Region: 2025-2030
3.3 Global Pulmonary Drug Delivery Devices & Systems Global Pulmonary Drug Delivery Devices & Systems Revenue by Region: 2019-2030
3.3.1 Global Pulmonary Drug Delivery Devices & Systems Revenue by Region: 2019-2024
3.3.2 Global Pulmonary Drug Delivery Devices & Systems Revenue by Region: 2025-2030
3.4 North America Pulmonary Drug Delivery Devices & Systems Market Facts & Figures by Country
3.4.1 North America Pulmonary Drug Delivery Devices & Systems Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Pulmonary Drug Delivery Devices & Systems Sales by Country (2019-2030)
3.4.3 North America Pulmonary Drug Delivery Devices & Systems Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Pulmonary Drug Delivery Devices & Systems Market Facts & Figures by Country
3.5.1 Europe Pulmonary Drug Delivery Devices & Systems Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Pulmonary Drug Delivery Devices & Systems Sales by Country (2019-2030)
3.5.3 Europe Pulmonary Drug Delivery Devices & Systems Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Pulmonary Drug Delivery Devices & Systems Market Facts & Figures by Country
3.6.1 Asia Pacific Pulmonary Drug Delivery Devices & Systems Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Pulmonary Drug Delivery Devices & Systems Sales by Country (2019-2030)
3.6.3 Asia Pacific Pulmonary Drug Delivery Devices & Systems Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Pulmonary Drug Delivery Devices & Systems Market Facts & Figures by Country
3.7.1 Latin America Pulmonary Drug Delivery Devices & Systems Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Pulmonary Drug Delivery Devices & Systems Sales by Country (2019-2030)
3.7.3 Latin America Pulmonary Drug Delivery Devices & Systems Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Pulmonary Drug Delivery Devices & Systems Market Facts & Figures by Country
3.8.1 Middle East and Africa Pulmonary Drug Delivery Devices & Systems Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Pulmonary Drug Delivery Devices & Systems Sales by Country (2019-2030)
3.8.3 Middle East and Africa Pulmonary Drug Delivery Devices & Systems Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Pulmonary Drug Delivery Devices & Systems Sales by Type (2019-2030)
4.1.1 Global Pulmonary Drug Delivery Devices & Systems Sales by Type (2019-2024)
4.1.2 Global Pulmonary Drug Delivery Devices & Systems Sales by Type (2025-2030)
4.1.3 Global Pulmonary Drug Delivery Devices & Systems Sales Market Share by Type (2019-2030)
4.2 Global Pulmonary Drug Delivery Devices & Systems Revenue by Type (2019-2030)
4.2.1 Global Pulmonary Drug Delivery Devices & Systems Revenue by Type (2019-2024)
4.2.2 Global Pulmonary Drug Delivery Devices & Systems Revenue by Type (2025-2030)
4.2.3 Global Pulmonary Drug Delivery Devices & Systems Revenue Market Share by Type (2019-2030)
4.3 Global Pulmonary Drug Delivery Devices & Systems Price by Type (2019-2030)
5 Segment by Application
5.1 Global Pulmonary Drug Delivery Devices & Systems Sales by Application (2019-2030)
5.1.1 Global Pulmonary Drug Delivery Devices & Systems Sales by Application (2019-2024)
5.1.2 Global Pulmonary Drug Delivery Devices & Systems Sales by Application (2025-2030)
5.1.3 Global Pulmonary Drug Delivery Devices & Systems Sales Market Share by Application (2019-2030)
5.2 Global Pulmonary Drug Delivery Devices & Systems Revenue by Application (2019-2030)
5.2.1 Global Pulmonary Drug Delivery Devices & Systems Revenue by Application (2019-2024)
5.2.2 Global Pulmonary Drug Delivery Devices & Systems Revenue by Application (2025-2030)
5.2.3 Global Pulmonary Drug Delivery Devices & Systems Revenue Market Share by Application (2019-2030)
5.3 Global Pulmonary Drug Delivery Devices & Systems Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Hovione
6.1.1 Hovione Corporation Information
6.1.2 Hovione Description and Business Overview
6.1.3 Hovione Pulmonary Drug Delivery Devices & Systems Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Hovione Pulmonary Drug Delivery Devices & Systems Product Portfolio
6.1.5 Hovione Recent Developments/Updates
6.2 3M Health Care
6.2.1 3M Health Care Corporation Information
6.2.2 3M Health Care Description and Business Overview
6.2.3 3M Health Care Pulmonary Drug Delivery Devices & Systems Sales, Revenue and Gross Margin (2019-2024)
6.2.4 3M Health Care Pulmonary Drug Delivery Devices & Systems Product Portfolio
6.2.5 3M Health Care Recent Developments/Updates
6.3 Bespak
6.3.1 Bespak Corporation Information
6.3.2 Bespak Description and Business Overview
6.3.3 Bespak Pulmonary Drug Delivery Devices & Systems Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Bespak Pulmonary Drug Delivery Devices & Systems Product Portfolio
6.3.5 Bespak Recent Developments/Updates
6.4 BeyonDevices
6.4.1 BeyonDevices Corporation Information
6.4.2 BeyonDevices Description and Business Overview
6.4.3 BeyonDevices Pulmonary Drug Delivery Devices & Systems Sales, Revenue and Gross Margin (2019-2024)
6.4.4 BeyonDevices Pulmonary Drug Delivery Devices & Systems Product Portfolio
6.4.5 BeyonDevices Recent Developments/Updates
6.5 GlaxoSmithKline
6.5.1 GlaxoSmithKline Corporation Information
6.5.2 GlaxoSmithKline Description and Business Overview
6.5.3 GlaxoSmithKline Pulmonary Drug Delivery Devices & Systems Sales, Revenue and Gross Margin (2019-2024)
6.5.4 GlaxoSmithKline Pulmonary Drug Delivery Devices & Systems Product Portfolio
6.5.5 GlaxoSmithKline Recent Developments/Updates
6.6 H&T Presspart
6.6.1 H&T Presspart Corporation Information
6.6.2 H&T Presspart Description and Business Overview
6.6.3 H&T Presspart Pulmonary Drug Delivery Devices & Systems Sales, Revenue and Gross Margin (2019-2024)
6.6.4 H&T Presspart Pulmonary Drug Delivery Devices & Systems Product Portfolio
6.6.5 H&T Presspart Recent Developments/Updates
6.7 PARI Respiratory Equipment
6.6.1 PARI Respiratory Equipment Corporation Information
6.6.2 PARI Respiratory Equipment Description and Business Overview
6.6.3 PARI Respiratory Equipment Pulmonary Drug Delivery Devices & Systems Sales, Revenue and Gross Margin (2019-2024)
6.4.4 PARI Respiratory Equipment Pulmonary Drug Delivery Devices & Systems Product Portfolio
6.7.5 PARI Respiratory Equipment Recent Developments/Updates
6.8 Philips Respironics
6.8.1 Philips Respironics Corporation Information
6.8.2 Philips Respironics Description and Business Overview
6.8.3 Philips Respironics Pulmonary Drug Delivery Devices & Systems Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Philips Respironics Pulmonary Drug Delivery Devices & Systems Product Portfolio
6.8.5 Philips Respironics Recent Developments/Updates
6.9 SHL
6.9.1 SHL Corporation Information
6.9.2 SHL Description and Business Overview
6.9.3 SHL Pulmonary Drug Delivery Devices & Systems Sales, Revenue and Gross Margin (2019-2024)
6.9.4 SHL Pulmonary Drug Delivery Devices & Systems Product Portfolio
6.9.5 SHL Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Pulmonary Drug Delivery Devices & Systems Industry Chain Analysis
7.2 Pulmonary Drug Delivery Devices & Systems Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Pulmonary Drug Delivery Devices & Systems Production Mode & Process
7.4 Pulmonary Drug Delivery Devices & Systems Sales and Marketing
7.4.1 Pulmonary Drug Delivery Devices & Systems Sales Channels
7.4.2 Pulmonary Drug Delivery Devices & Systems Distributors
7.5 Pulmonary Drug Delivery Devices & Systems Customers
8 Pulmonary Drug Delivery Devices & Systems Market Dynamics
8.1 Pulmonary Drug Delivery Devices & Systems Industry Trends
8.2 Pulmonary Drug Delivery Devices & Systems Market Drivers
8.3 Pulmonary Drug Delivery Devices & Systems Market Challenges
8.4 Pulmonary Drug Delivery Devices & Systems Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
